Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of ImmunityBio, Inc. (NASDAQ: IBRX), focusing on possible self-dealing that may entitle shareholders to damages and corporate governance reforms [1]. Group 1 - The investigation by Kuehn Law concerns whether ImmunityBio's management acted in the best interests of shareholders [1]. - Shareholders may have the right to seek damages and demand changes in corporate governance practices as a result of the investigation [1]. - The law firm emphasizes the importance of shareholder participation in maintaining the integrity of financial markets [4]. Group 2 - Kuehn Law offers free consultations and covers all case costs for shareholders who wish to participate in the investigation [3]. - Shareholders are encouraged to contact Kuehn Law promptly due to potential time limitations on enforcing their rights [3]. - The firm highlights that shareholder involvement is crucial for ensuring fairness in the financial markets [4].